Pharmacological activity of capsaicin : Mechanisms and controversies (Review)
Capsaicin, which is abundant in chili peppers, exerts antioxidative, antitumor, antiulcer and analgesic effects and it has demonstrated potential as a treatment for cardiovascular, gastrointestinal, oncological and dermatological conditions. Unique among natural irritants, capsaicin initially excites neurons but then 'calms' them into long‑lasting non‑responsiveness. Capsaicin can also promote weight loss, making it potentially useful for treating obesity. Several mechanisms have been proposed to explain the therapeutic effects of capsaicin, including antioxidation, analgesia and promotion of apoptosis. Some of the mechanisms are proposed to be mediated by the capsaicin receptor (transient receptor potential cation channel subfamily V member 1), but some are proposed to be independent of that receptor. The clinical usefulness of capsaicin is limited by its short half‑life. The present review provided an overview of what is known about the therapeutic effects of capsaicin and the mechanisms involved and certain studies arguing against its clinical use were mentioned.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:29 |
---|---|
Enthalten in: |
Molecular medicine reports - 29(2024), 3 vom: 02. Feb. |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Zhang, Wei [VerfasserIn] |
---|
Links: |
---|
Themen: |
Capsaicin |
---|
Anmerkungen: |
Date Completed 22.01.2024 Date Revised 02.02.2024 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.3892/mmr.2024.13162 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM367305755 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM367305755 | ||
003 | DE-627 | ||
005 | 20240202232147.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240119s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.3892/mmr.2024.13162 |2 doi | |
028 | 5 | 2 | |a pubmed24n1278.xml |
035 | |a (DE-627)NLM367305755 | ||
035 | |a (NLM)38240083 | ||
035 | |a (PII)38 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Zhang, Wei |e verfasserin |4 aut | |
245 | 1 | 0 | |a Pharmacological activity of capsaicin |b Mechanisms and controversies (Review) |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 22.01.2024 | ||
500 | |a Date Revised 02.02.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Capsaicin, which is abundant in chili peppers, exerts antioxidative, antitumor, antiulcer and analgesic effects and it has demonstrated potential as a treatment for cardiovascular, gastrointestinal, oncological and dermatological conditions. Unique among natural irritants, capsaicin initially excites neurons but then 'calms' them into long‑lasting non‑responsiveness. Capsaicin can also promote weight loss, making it potentially useful for treating obesity. Several mechanisms have been proposed to explain the therapeutic effects of capsaicin, including antioxidation, analgesia and promotion of apoptosis. Some of the mechanisms are proposed to be mediated by the capsaicin receptor (transient receptor potential cation channel subfamily V member 1), but some are proposed to be independent of that receptor. The clinical usefulness of capsaicin is limited by its short half‑life. The present review provided an overview of what is known about the therapeutic effects of capsaicin and the mechanisms involved and certain studies arguing against its clinical use were mentioned | ||
650 | 4 | |a Review | |
650 | 4 | |a Journal Article | |
650 | 4 | |a capsaicin | |
650 | 4 | |a mechanisms | |
650 | 4 | |a pharmacological | |
650 | 4 | |a transient receptor potential cation channel subfamily V member 1 | |
650 | 7 | |a Capsaicin |2 NLM | |
650 | 7 | |a S07O44R1ZM |2 NLM | |
650 | 7 | |a TRPV Cation Channels |2 NLM | |
700 | 1 | |a Zhang, Yu |e verfasserin |4 aut | |
700 | 1 | |a Fan, Jinke |e verfasserin |4 aut | |
700 | 1 | |a Feng, Zhiguo |e verfasserin |4 aut | |
700 | 1 | |a Song, Xinqiang |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Molecular medicine reports |d 2008 |g 29(2024), 3 vom: 02. Feb. |w (DE-627)NLM192195727 |x 1791-3004 |7 nnns |
773 | 1 | 8 | |g volume:29 |g year:2024 |g number:3 |g day:02 |g month:02 |
856 | 4 | 0 | |u http://dx.doi.org/10.3892/mmr.2024.13162 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 29 |j 2024 |e 3 |b 02 |c 02 |